Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Arock

Showing results (1-10 of 177) with videos related to

Pageof 18
Sort By:
Lancet (London, England)|January 11, 2017
A new therapeutic advance for symptomatic systemic mastocytosis?Michel Arock
Blood|January 30, 2016
Mast cell differentiation: still open questions?Michel Arock
Expert Review of Hematology|November 19, 2010
Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectivesMichel Arock, Peter Valent
Frontiers in Allergy|July 4, 2025
Hereditary alpha-tryptasemia and monoclonal mast cell disordersYannick Chantran, Michel Arock
The British Journal of Dermatology|July 5, 2023
Is lirentelimab the 'magic bullet' to fight pathological mast-cell activation in systemic mastocytosis?Stéphane Barete, Michel Arock
Immunology and Allergy Clinics of North America|July 16, 2018
Tyrosine Kinase Inhibition in Mastocytosis: KIT and Beyond KITSiham Bibi, Michel Arock
Blood|November 27, 2025
MASTering KIT: enhanced sensitivity for refined diagnosisYannick Chantran, Michel Arock
Blood|July 25, 2024
Diagnosis of mastocytosis: emerging iceberg?Julien Rossignol, Michel Arock
International Journal of Cancer|November 21, 2014
The increasing roles of epigenetics in breast cancer: Implications for pathogenicity, biomarkers, prevention and treatmentClémence Basse, Michel Arock
Immunology and Allergy Clinics of North America|September 27, 2023
KIT Mutations and Other Genetic Defects in Mastocytosis: Implications for Disease Pathology and Targeted TherapiesYannick Chantran, Peter Valent, Michel Arock
Pageof 18

Showing results (1-10 of 177) with videos related to

Sort By:
Pageof 18
Lancet (London, England)|January 11, 2017
A new therapeutic advance for symptomatic systemic mastocytosis?Michel Arock
Blood|January 30, 2016
Mast cell differentiation: still open questions?Michel Arock
Expert Review of Hematology|November 19, 2010
Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectivesMichel Arock, Peter Valent
Frontiers in Allergy|July 4, 2025
Hereditary alpha-tryptasemia and monoclonal mast cell disordersYannick Chantran, Michel Arock
The British Journal of Dermatology|July 5, 2023
Is lirentelimab the 'magic bullet' to fight pathological mast-cell activation in systemic mastocytosis?Stéphane Barete, Michel Arock
Immunology and Allergy Clinics of North America|July 16, 2018
Tyrosine Kinase Inhibition in Mastocytosis: KIT and Beyond KITSiham Bibi, Michel Arock
Blood|November 27, 2025
MASTering KIT: enhanced sensitivity for refined diagnosisYannick Chantran, Michel Arock
Blood|July 25, 2024
Diagnosis of mastocytosis: emerging iceberg?Julien Rossignol, Michel Arock
International Journal of Cancer|November 21, 2014
The increasing roles of epigenetics in breast cancer: Implications for pathogenicity, biomarkers, prevention and treatmentClémence Basse, Michel Arock
Immunology and Allergy Clinics of North America|September 27, 2023
KIT Mutations and Other Genetic Defects in Mastocytosis: Implications for Disease Pathology and Targeted TherapiesYannick Chantran, Peter Valent, Michel Arock
Pageof 18